FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Acta veterinaria Scandinavica1995; 36(2); 223-236; doi: 10.1186/BF03547691

Equine sarcoids. A clinical and epidemiological study in relation to equine leucocyte antigens (ELA).

Abstract: Associations between clinical parameters of sarcoids and the equine leucocyte antigen system (ELA) were analysed for 120 Swedish horses. Median age of affected horses was 5.2 years, and the majority presented with solitary tumors between 2 and 5 cm in diameter and ventral abdomen was a predilection site. Clinical signs first appeared at a median age of 3.5 years, and sarcoids at different locations first appeared at different ages. Lesions at different sites differed in size, and multiple tumors, early onset, long duration, and older age all had an association with large size. Clinical manifestations of sarcoids and the association between certain ELA-specificities and early onset (A5) and increased recurrence rates after surgery (W13), in addition to increased prevalence (A3W13), strengthen further that some horses are inherently predisposed to sarcoid growth. Unassociated with any clinical parameters, one third of the untreated horses became free of sarcoids due to "spontaneous" regression, perhaps as a result of immune responses against the tumors. Seventy percent of the horses were treated (mostly by excision), and large size was the main parameter promoting treatment. Excision had no significant effect on possibly remaining sarcoids. Recurrence rate after first treatment was about 35%, with the majority of tumors recurring within 4 months. Early onset, long duration, large size, and localization to distal limbs all appeared to increase risk of recurrence. Early treatment, performed under general anesthesia in recumbency which permits wide excision and measures to avoid autoinoculation, significantly reduced recurrence rates.
Get Full Text
Publication Date: 1995-01-01 PubMed ID: 7484549PubMed Central: PMC8095413DOI: 10.1186/BF03547691Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article investigates the link between clinical parameters of sarcoids, a type of benign tumor in horses, and the equine leucocyte antigen system. The study focuses on 120 Swedish horses and explores factors such as age at the onset of sarcoids, size and location of tumors, recurrence rates, and treatment strategies.

About the Research

  • This study is a clinical and epidemiological exploration of equine sarcoids, a common benign tumor in horses.
  • It involves 120 Swedish horses, providing a substantial sample for the study.
  • The researchers paid particular attention to potential connections between the sarcoids and the equine leucocyte antigen system (ELA), an essential part of the immune system in horses.

Key Findings

  • The median age of affected horses was 5.2 years, and solitary tumors with a diameter of 2 – 5 cm on the ventral abdomen were common.
  • Symptoms first appeared on average at 3.5 years, and the age at which sarcoids first showed varied depending on their location.
  • Tumors at different locations had distinct sizes and a correlation was found between multiple tumors, early onset, prolonged duration, and advanced age with larger tumors.

Role of ELA

  • Researchers observed a connection between certain ELA specificities and early onset of sarcoids, as well as higher recurrence rates after surgery.
  • This discovery supports the theory that some horses may have a genetic predisposition to develop these benign tumors.

Treatment and Recurrence

  • About 70% of the horses were treated, mostly through excision, with large size being the main factor prompting treatment.
  • Interestingly, about a third of the horses that did not receive treatment saw a “spontaneous” regression of the sarcoids, indicating a possible immune response to the tumors.
  • The recurrence rate after initial treatment was approximately 35%, with most recurrence happening within the first four months.
  • Risk factors for recurrence included early onset, long duration, large size, and location on distal limbs.
  • Early treatment under general anesthesia, involving extensive excision and measures to prevent the spread of the tumors, significantly reduced recurrence rates.

Cite This Article

APA
Broström H. (1995). Equine sarcoids. A clinical and epidemiological study in relation to equine leucocyte antigens (ELA). Acta Vet Scand, 36(2), 223-236. https://doi.org/10.1186/BF03547691

Publication

Acta veterinaria Scandinavica
ISSN: 0044-605X
NlmUniqueID: 0370400
Country: England
Language: English
Volume: 36
Issue: 2
Pages: 223-236

Researcher Affiliations

Broström, H
  • Department of Medicine and Surgery, Swedish University of Agricultural Sciences, Uppsala.

MeSH Terms

  • Age Factors
  • Analysis of Variance
  • Animals
  • Disease Progression
  • Female
  • Histocompatibility Antigens / immunology
  • Horse Diseases / epidemiology
  • Horse Diseases / immunology
  • Horse Diseases / therapy
  • Horses
  • Leukocytes / immunology
  • Male
  • Neoplasm Regression, Spontaneous
  • Recurrence
  • Retrospective Studies
  • Risk Assessment
  • Sex Factors
  • Skin Neoplasms / epidemiology
  • Skin Neoplasms / immunology
  • Skin Neoplasms / therapy
  • Skin Neoplasms / veterinary
  • Treatment Outcome

References

This article includes 44 references
  1. Angelos J, Oppenheim Y, Rebhun W, Mohammed H, Antczak DF. Evaluation of breed as a risk factor for sarcoid and uveitis in horses. Anim. Genet. 1988;19:417–425.
    doi: 10.1111/j.1365-2052.1988.tb00833.xpubmed: 3232865google scholar: lookup
  2. Baker JR, Leyland A. Histological survey of tumours of the horse, with particular reference to those of the skin. Vet. Rec. 1975;96:243–249.
    doi: 10.1136/vr.96.11.243pubmed: 1173477google scholar: lookup
  3. Bastianello SS. A survey on neoplasia in domestic species over a 40-year period from 1935 to 1974 in the Republic of South Africa IV. Ilimours occurring in Equidae. Onderstepoort J. vet. Res. 1983;59:91–96.
    pubmed: 6634089
  4. Broström H, Bredberg-Ràdén U, England JJ, Obel N, Perlmann P. Cell-mediated immunity in horses with sarcoid tumors against sarcoid cells in vitro. Amer. J. vet. Res. 1979;40:1701–1706.
    pubmed: 525888
  5. Broström H, Fahlbrink E, Dubath M-L, Lazary S. Association between equine leucocyte antigens (ELA) and equine sarcoid tumors in the population of Swedish halfbreds and some of their families. Vet. Immunol. Immunopathol. 1988;19:215–223.
    doi: 10.1016/0165-2427(88)90109-2pubmed: 3252614google scholar: lookup
  6. Cheevers WP, Fatemi-Nainie S, Anderson LW. Spontaneous expression of an endogenous retrovirus by the equine sarcoid-derived Mc-1 cell line. Amer. J. vet. Res. 1986;47:50–52.
    pubmed: 3946909
  7. Cotchin E. A general survey of tumours in the horse. Equine Vet. J. 1977;9:16–21.
    doi: 10.1111/j.2042-3306.1977.tb03964.xpubmed: 319996google scholar: lookup
  8. Cotchin E, Baker-Smith J. Tumours in horses encountered in an abbatoir survey. Vet. Rec. 1975;97:339.
    doi: 10.1136/vr.97.17.339-apubmed: 1198876google scholar: lookup
  9. Diehl M, Vingerhoets M, Stornetta D. Spezifische Methoden zur Ernfernung des Equinen Sar-kodes (Specific methods for removing equine sarcoids). Prakt. Tierazt. 1988;69:14–17.
  10. England JJ, Watson RE, Larson KA. Virus-like particles in an equine sarcoid cell line. Amer. J. vet. Res. 1973;34:1601–1603.
    pubmed: 4796998
  11. Fretz PB, Barber SM. Prospective analysis of cryosurgery as the sole treatment for equine sarcoids. Vet.Clin. North Amer/Small Anim.Pract. 1980;10:847–859.
    doi: 10.1016/S0195-5616(80)50085-9pubmed: 6972661google scholar: lookup
  12. Ivascu I, Muresan GSE, Pápay Z. Clinical and pathological observations on 5 cases of equine sarcoidosis in Romania. Zbl. Vet. Med. 1974;21:815–823.
    doi: 10.1111/j.1439-0442.1974.tb01342.xpubmed: 4217063google scholar: lookup
  13. Jackson C. The incidence and pathology of tumours of domestic animals in South Africa. Onderstepoort J. Vet. Sei. Anim. Ind. 1936;6:241–248.
  14. James VS. A family tendency to equine sarcoids. S. West Vet. 1968;27:235–236.
  15. Kersjes AW, Ruitenberg EJ. Equine sarcoid: BCG immunotherapy compared to cryosurgery in a prospective randomized clinical trial. Cancer Immunol. Immunother. 1986;27:133–140.
    pmc: PMC11038812pubmed: 3633215
  16. Klein WR, Goosen EB, Misdorp W, Steerenberg PA, de Jong WH, Tiesjema RH, Lane JG. The treatment of equine sarcoids by cryosurgery. Equine Vet. J. 1977;9:127–133.
    doi: 10.1111/j.2042-3306.1977.tb04003.xpubmed: 891516google scholar: lookup
  17. Knottenbelt DC, Walker JA. Topical treatment of the equine sarcoid. Equine vet. Educ. 1994;6:72–75.
    doi: 10.1111/j.2042-3292.1994.tb01089.xgoogle scholar: lookup
  18. Laursen BA. Behandling af equine sarcoider med kryokirurgi (Cryosurgery as treatment of equine sarcoids). Dansk Vet. Tidskr. 1987;70:97–104.
  19. Lazary S, Antczak DF, Bailey E, Bell TK, Bernoco D, Byrns G, McClure JJ. Joint report of the fifth international workshop on lymphocyte alloantigens of the horse. Anim. Gen. 1988;79:447–456.
    pubmed: 2466424
  20. Lazary S, Gerber H, Glatt PA, Straub R. Equine leucocyte antigens in sarcoid-affected horses. Equine vet. J. 1985;77:283–286.
    doi: 10.1111/j.2042-3306.1985.tb02498.xpubmed: 3865769google scholar: lookup
  21. Lory S, Tscharner C, Marti E, Bestetti G, Grimm S, Waldvogel A. In situ hybridization of equine sarcoids with bovine papilloma virus. Vet Rec. 1993;132:132–133.
    doi: 10.1136/vr.132.6.132pubmed: 8383371google scholar: lookup
  22. Madewell BR, Theilen GH. Skin tumors of mesenchymal origin. In: Theilen GH, Madewell BR, editors. Veterinary Cancer Medicine. 2nd. Philadelphia: Lea & Febiger; 1987. pp. 282–309.
  23. Marti E, Lazary S, Antczak DF, Gerber H. Report of the first international workshop on equine sarcoid. Equine vet. J. 1993;25:397–407.
    doi: 10.1111/j.2042-3306.1993.tb02981.xpubmed: 8223371google scholar: lookup
  24. Meridith D, Elser AH, Wolf B, Soma LR, Donawick WJ, Lazary S. Equine leucocyte antigens: Relationships with sarcoid tumors and laminitis in 2 pure breeds. Immunogen. 1986;23:221–225.
    doi: 10.1007/BF00373016pubmed: 3699852google scholar: lookup
  25. Miller R, Campbell RSF. A survey of granulomatous and neoplastic diseases of equine skin in north Queensland. Austr. vet. J. 1982;59:33–37.
    doi: 10.1111/j.1751-0813.1982.tb02711.xpubmed: 7150129google scholar: lookup
  26. Mohammed HO, Rebhun WC, Antczak DF. Factors associated with the risk of developing sarcoid tumours in horses. Equine vet. J. 1992;24:165–168.
    doi: 10.1111/j.2042-3306.1992.tb02808.xpubmed: 1606927google scholar: lookup
  27. Onion D. Tumor immunology. In: Theilen GH, Madewell BR, editors. Veterinary Cancer Medicine. 2nd. Philadelphia: Lea & Febiger; 1987. pp. 105–119.
  28. Otten N, Tscharner C, Lazary S, Antczak DF, Gerber H. DNA of bovine papilloma virus type 1 and 2 in equine sarcoids: PCR detection and direct sequencing. Arch. Virol. 1993;132:121–131.
    doi: 10.1007/BF01309847pubmed: 8394687google scholar: lookup
  29. Pascoe RR. The nature of skin conditions observed in horses in Queensland. Austr. vet. J. 1973;49:35–40.
    doi: 10.1111/j.1751-0813.1973.tb14677.xpubmed: 4347694google scholar: lookup
  30. Pascoe RR. A Colour Atlas of Equine Dermatology. London: Wolfe Publishing Limited; 1990. pp. 75–83.
  31. Ragland WL, Keown GH, Gorham JR. An epizootic of equine sarcoid. Nature 1966;210:1399.
    doi: 10.1038/2101399a0pubmed: 6007121google scholar: lookup
  32. Ragland WL, Keown GH, Spencer GR. Equine sarcoid. Equine vet. J. 1970;2:2–11.
    doi: 10.1111/j.2042-3306.1970.tb04145.xgoogle scholar: lookup
  33. Raphel CF. Diseases of the equine eyelid. Comp. Cont. Educ. 1982;4:14–21.
  34. Reid SWJ, Gettinby G, Fowler JN, Ikin P. Epidemiological observations on sarcoids in a population of donkeys (Equus asinus). Vet. Rec. 1994;134:207–211.
    doi: 10.1136/vr.134.9.207pubmed: 8171807google scholar: lookup
  35. Roberts WD. Experimental treatment of equine sarcoid. Vet. Med/small Anim. Clin. 1970;65:67–73.
    pubmed: 5198018
  36. Schwartzmann SM, Cantrell JL, Ribi ER, Ward J. Immunotherapy of equine sarcoid with cell wall skeleton (CWS)-threhalose dimycolate (TDM) biologic. Equine Pract. 1984;6:13–23.
  37. Stannard AA, Pulley LD. Tumors of the skin and soft tissues. In: Moulton JE, editor. Tumors in domestic animals. 2nd. Berkeley: University of California Press; 1978. pp. 16–74.
  38. Sundberg JP, Burnstein T, Page EH, Kirkham WW, Robinson FR. Neoplasms of equidae. J. Amer, vet. med. Assoc. 1977;170:150–152.
    pubmed: 576219
  39. Tallberg TH, Kinnunen RE, Palkama A, Saario EMK, Borgström G. Equine sarcoid successfully treated by Bio-Immunotherapy. Dtsch. Zschr. Onkol. 1994;26:34–40.
  40. Theon AP, Pascoe JR, Carlson GP, Krag DN. Intratumoral chemotherapy with cisplatin in oily emulsions in horses. J. Amer. vet. med. Assoc. 1993;262:261–267.
    pubmed: 8428832
  41. Turrel JM, Stover SM, Gyorgfalvy J. Iridium-192 interstitial brachytherapy of equine sarcoid. Vet. Radiol. 1985;26:20–24.
    doi: 10.1111/j.1740-8261.1985.tb01109.xgoogle scholar: lookup
  42. Voss JL. Transmission of equine sarcoid. Amer. J. vet. Res. 1969;56:183–191.
    pubmed: 5392976
  43. Watson RE, Larson KA. Detection of tumor-specific antigens in an equine sarcoid cell line. Infect, and Immun. 1974;9:714–718.
    doi: 10.1128/IAI.9.4.714-718.1974pmc: PMC414871pubmed: 4595759google scholar: lookup
  44. Wilcock BP. Neoplastic diseases of skin and mammary gland. In: Jubb KVF, Kennel PC, Palmer N, editors. Pathology of domestic animals. 4th. San Diego: Academic Press Inc.; 1993. pp. 706–729.

Citations

This article has been cited 11 times.
  1. Vychodilova L, Plasil M, Futas J, Kopecka A, Molinkova D, Wijacki T, Jahn P, Knoll A, Horin P. Genetic susceptibility to sarcoid in Arabian horses: associations with MHC class II and compound MHC class I/KLRA genotypes. Vet Res Commun 2025 May 1;49(3):184.
    doi: 10.1007/s11259-025-10748-2pubmed: 40310488google scholar: lookup
  2. De Falco F, Cutarelli A, Pellicanò R, Brandt S, Roperto S. Molecular Detection and Quantification of Ovine Papillomavirus DNA in Equine Sarcoid. Transbound Emerg Dis 2024;2024:6453158.
    doi: 10.1155/2024/6453158pubmed: 40303025google scholar: lookup
  3. Karalus W, Subharat S, Orbell G, Vaatstra B, Munday JS. Equine sarcoids: A clinicopathologic study of 49 cases, with mitotic count and clinical type predictive of recurrence. Vet Pathol 2024 May;61(3):357-365.
    doi: 10.1177/03009858231209408pubmed: 37937724google scholar: lookup
  4. Monod A, Koch C, Jindra C, Haspeslagh M, Howald D, Wenker C, Gerber V, Rottenberg S, Hahn K. CRISPR/Cas9-Mediated Targeting of BPV-1-Transformed Primary Equine Sarcoid Fibroblasts. Viruses 2023 Sep 17;15(9).
    doi: 10.3390/v15091942pubmed: 37766348google scholar: lookup
  5. Jindra C, Hainisch EK, Brandt S. Immunotherapy of Equine Sarcoids-From Early Approaches to Innovative Vaccines. Vaccines (Basel) 2023 Mar 30;11(4).
    doi: 10.3390/vaccines11040769pubmed: 37112681google scholar: lookup
  6. Pawlina-Tyszko K, Semik-Gurgul E, Ząbek T, Witkowski M. Methylation Status of Gene Bodies of Selected microRNA Genes Associated with Neoplastic Transformation in Equine Sarcoids. Cells 2022 Jun 14;11(12).
    doi: 10.3390/cells11121917pubmed: 35741046google scholar: lookup
  7. Cosandey J, Hamza E, Gerber V, Ramseyer A, Leeb T, Jagannathan V, Blaszczyk K, Unger L. Diagnostic and prognostic potential of eight whole blood microRNAs for equine sarcoid disease. PLoS One 2021;16(12):e0261076.
    doi: 10.1371/journal.pone.0261076pubmed: 34941894google scholar: lookup
  8. Unger L, Jagannathan V, Pacholewska A, Leeb T, Gerber V. Differences in miRNA differential expression in whole blood between horses with sarcoid regression and progression. J Vet Intern Med 2019 Jan;33(1):241-250.
    doi: 10.1111/jvim.15375pubmed: 30506726google scholar: lookup
  9. Wilson AD, Hicks C. Both tumour cells and infiltrating T-cells in equine sarcoids express FOXP3 associated with an immune-supressed cytokine microenvironment. Vet Res 2016 May 9;47(1):55.
    doi: 10.1186/s13567-016-0339-8pubmed: 27160146google scholar: lookup
  10. Wobeser BK, Davies JL, Hill JE, Jackson ML, Kidney BA, Mayer MN, Townsend HG, Allen AL. Epidemiology of equine sarcoids in horses in western Canada. Can Vet J 2010 Oct;51(10):1103-8.
    pubmed: 21197201
  11. Postey RC, Appleyard GD, Kidney BA. Evaluation of equine papillomas, aural plaques, and sarcoids for the presence of Equine papillomavirus DNA and Papillomavirus antigen. Can J Vet Res 2007 Jan;71(1):28-33.
    pubmed: 17193879
Subscribe to our newsletter
Join 100,191 horse owners like you who receive our email updates on horse health and nutrition.